Top Markets
Coin of the day
Avivagen Inc. Avivagen Inc.

Avivagen Inc.

VIV
Rank in Stocks #40244
Avivagen Inc. is a life sciences enterprise that invents and sells specialized... Avivagen Inc. is a life sciences enterprise that invents and sells specialized products, primarily for animal feed, aimed at bolstering the immune systems of livestock. These solutions are designed to enhance animals' health, leading to improved growth and overall productivity. The company's diverse product lineup features OxC-beta Livestock, a crucial premix for farm animal diets. Beyond agriculture, Avivagen also manufactures health supplements such as Vivamune and Dr. Tobias-branded chews for dogs, along with the Dr. Tobias Beta blend, formulated to support human immunity. Established in 2005 and based in Ottawa, Canada, Avivagen Inc. distributes its offerings across numerous international markets, including the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia.
Share Price
$0.00368316
Last synced: 2024-03-04
Market Cap
$199.43K
Change (1 day)
0.05%
Change (1 year)
0.00%
Country
CA
Trade Avivagen Inc. (VIV)

Category

Price of VIV with the market cap of B
Avivagen Inc. Avivagen Inc.
VIV
$0.00368316
Market Capitalization of Avivagen Inc.(VIV)
Market Cap: $199.43K
As of August 2026 Avivagen Inc. has a market cap of $199.43K. This makes Avivagen Inc. the world's 40244th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Avivagen Inc. from 2007 to 2026
VIV compared with Top 5 Most Popular stocks
Price of VIV Asset B Mkt. of B Results
Avivagen Inc. Avivagen Inc.
$101,013 $199.43K
$5.470T +2,742,557,322.10%
Avivagen Inc. Avivagen Inc.
$82,499.03 $199.43K
$4.467T +2,239,896,538.59%
Avivagen Inc. Avivagen Inc.
$77,093.65 $199.43K
$4.174T +2,093,137,341.70%
Avivagen Inc. Avivagen Inc.
$68,333.99 $199.43K
$3.700T +1,855,307,404.84%
Avivagen Inc. Avivagen Inc.
$52,714.74 $199.43K
$2.854T +1,431,235,787.47%